Owlet (OWLT) Shares Outstanding (Weighted Average) (2020 - 2026)
Owlet (OWLT) reported Shares Outstanding (Weighted Average) of $27.4 million for Q1 2026, up 78.22% year-over-year from $15.4 million in Q1 2025, and up 1547.12% quarter-over-quarter from $1.7 million in Q4 2025.
Owlet (OWLT) Shares Outstanding (Weighted Average) (2020 - 2026) Analysis & Trends
Owlet (OWLT) has 7 years of Shares Outstanding (Weighted Average) data on file, last reported at $27.4 million in Q1 2026.
- Shares Outstanding (Weighted Average) for Q1 2026 came in at $27.4 million, up 78.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $27.4 million (up 78.22% YoY), and the FY2025 annual result was $18.1 million, up 63.01% from the prior year.
- Shares Outstanding (Weighted Average) advanced to $27.4 million in Q1 2026 per OWLT's latest filing, from $1.7 million in the prior quarter.
- Over five years, Shares Outstanding (Weighted Average) peaked at $110.4 million in Q1 2022 and troughed at $1.7 million in Q4 2025.
- A 5-year average of $16.6 million and a median of $8.7 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
- The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Weighted Average) soared 396.47% in 2022, then tumbled 92.65% in 2023.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $8.0 million in 2022, then increased by 4.1% to $8.3 million in 2023, then jumped by 34.11% to $11.1 million in 2024, then plunged by 85.0% to $1.7 million in 2025, then surged by 1547.12% to $27.4 million in 2026.
- Business Quant data shows OWLT's Shares Outstanding (Weighted Average) at $27.4 million in Q1 2026, $1.7 million in Q4 2025, and $15.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 385.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 98.20 Mn |
| 10 | Owlet | 136.53 Mn | 95.52 Mn | 12.24 Mn | 27.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.42 Mn |
| Dec 31, 2025 | 1.66 Mn |
| Sep 30, 2025 | 15.77 Mn |
| Jun 30, 2025 | 15.55 Mn |
| Mar 31, 2025 | 15.38 Mn |
| Dec 31, 2024 | 11.10 Mn |
| Sep 30, 2024 | 11.04 Mn |
| Jun 30, 2024 | 8.80 Mn |
| Mar 31, 2024 | 8.74 Mn |
| Dec 31, 2023 | 8.28 Mn |
| Sep 30, 2023 | 8.21 Mn |
| Jun 30, 2023 | 8.21 Mn |
| Mar 31, 2023 | 8.11 Mn |
| Dec 31, 2022 | 7.95 Mn |
| Sep 30, 2022 | 7.93 Mn |
| Jun 30, 2022 | 7.90 Mn |
| Mar 31, 2022 | 110.38 Mn |
| Dec 31, 2021 | 63.22 Mn |
| Sep 30, 2021 | 96.68 Mn |
| Jun 30, 2021 | 22.38 Mn |